Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.

Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study, Am. J Med., 62, 707, 10.1016/0002-9343(77)90874-9 Miller, 1987, Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am, Heart J., 113, 589 Kannel, W. B., J. D. Neaton, D. Wentworth, H. E. Thomas, J. Stamler, S. B. Hulley, and M. 0. Kjelsberg, for the MRFIT Research Group. 1986. Overall and coronaryheart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am. HeartJ 112: 825-836. Gordon, 1986, High density lipoprotein cholesterol and coronary heart disease in hyper cholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial, Circulation., 74, 1217, 10.1161/01.CIR.74.6.1217 Manninen, 1992, Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment, Circulation., 85, 37, 10.1161/01.CIR.85.1.37 Genest, 1992, Lipoprotein cholesterol, apolipoprotein A-I and Band lipoprotein[a] abnormalities in men with premature coronary artery disease, J Am. Colt. Cardiol., 19, 792, 10.1016/0735-1097(92)90520-W Genest, 1991, Prevalence of risk factors in men with premature coronaryartery disease., Am. J Cardiol, 67, 1185, 10.1016/0002-9149(91)90924-A Panel, 1993, Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II), J Am. Med. Assoc., 269, 3015, 10.1001/jama.1993.03500230097036 Castro, 1988, Early incorporation of cell-derived cholesterol into pre-/3-migrating high-density lipoprotein, Biochemistry., 27, 25, 10.1021/bi00401a005 Barbaras, 1987, Cholesterol effiux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles, Biochem. Biophys. Res. Commun., 142, 63, 10.1016/0006-291X(87)90451-7 Rubin, 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I, Nature., 353, 265, 10.1038/353265a0 Karathanasis, 1987, DNA inversion within the apolipoproteins A-1/C-III/A-IV encoding gene cluster of certain patients with premature atherosclerosis, Proc. Nat!. Acad. Sci. USA., 84, 7198, 10.1073/pnas.84.20.7198 Ordovas, 1989, Familial apolipoprotein A-1, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11, J Bioi. Chem., 264, 16339, 10.1016/S0021-9258(19)84708-7 Matsunaga, 1991, Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-1 gene., Proc. Natl. Acad. Sci., 88, 2793, 10.1073/pnas.88.7.2793 Genest, 1992, Familial lipoprotein disorders in patients with premature coronary artery disease, Circulation., 85, 2025, 10.1161/01.CIR.85.6.2025 Schaefer, 1992, Diagnosis and management of high density lipoprotein deficiency states. In High Density Lipoproteins and Atherosclerosis. III., 235 Avogaro, 1979, Are apolipoproteins better discriminators than lipids for atherosclerosis, Lancet., 1, 901, 10.1016/S0140-6736(79)91375-8 Kottke, 1986, Apolipoproteins and coronary artery disease, Mayo Clin. Proc., 61, 313, 10.1016/S0025-6196(12)61947-8 Maciejko, 1983, Apolipoprotein A-I as a marker of angiographically assessed coronary artery disease, N Engl. J Med., 309, 385, 10.1056/NEJM198308183090701 Stampfer, 1991, A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction, N Engl. J Med., 325, 373, 10.1056/NEJM199108083250601 Axen, 1967, Chemical coupling of peptides and proteins to polysaccarides by means of cyanogen halides, Nature., 214, 1302, 10.1038/2141302a0 Lowry, 1951, Protein measurement with the Falin phenol reagent, J Biol. CMm., 193, 265 Ordovas, 1987, Enzyme-linked immunosorbent assay for human plasma apolipoprotein B., J Lipid Res., 28, 1216, 10.1016/S0022-2275(20)38611-9 Kannel, 1979, An investigation of coronary heart disease in families: the Framingham Offspring Study.Am., J Epidemiol., 110, 281, 10.1093/oxfordjournals.aje.a112813 Wilson, 1989, Impact of national guidelines for cholesterol risk factor screening: the Framingham Offspring Study, J Am. Med. Assoc., 262, 41, 10.1001/jama.1989.03430010053030 Group, 1990, Diet, nutrition, and the prevention of chronic diseases, World Health Organization Technical Report Series 797, Geneva., 69 Warnick, 1982, Dextran sulfate-Mg2+ precipitation procedure for quantitation of high density lipoprotein cholesterol, Clin. Chern., 28, 1379, 10.1093/clinchem/28.6.1379 McNamara, 1987, Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions, Clin. Chim. Acta., 166, 1, 10.1016/0009-8981(87)90188-4 Abbott, 1988, High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study, Arteriosclerosis., 8, 207, 10.1161/01.ATV.8.3.207 Gordon, 1989, High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies, Circulation., 79, 8, 10.1161/01.CIR.79.1.8 Schaefer, 1978, Plasma triglycerides in regulations of HDL-cholesterol levels, Lancet., 2, 391, 10.1016/S0140-6736(78)91863-9 Sprecher, 1993, The low HDL cholesterol/high triglyceride trait, Arterioscler. Thromb., 13, 495, 10.1161/01.ATV.13.4.495 Schaefer, 1982, Human apolipoprotein A-I and A-II metabolism, J Lipid Res., 23, 850, 10.1016/S0022-2275(20)38087-1 Schaefer, 1986, Metabolism of the apolipoproteins A-I, A-II, and A-IV, Methods Enzymol., 129, 420, 10.1016/0076-6879(86)29083-7 Brinton, 1991, Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein cholesterol levels with or without hypertriglyceridemia, J Clin. Invest., 87, 536, 10.1172/JCI115028 Cohn, 1988, Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-reach meal, J. Lipid Res., 29, 925, 10.1016/S0022-2275(20)38485-6 Tikkanen, 1987, Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am, Heart J, 113, 562 Goldberg, 1984, Acute inhibition of hepatic lipase and increase in plasma lipoproteins after alcohol intake, J Lipid Res., 25, 714, 10.1016/S0022-2275(20)37760-9 Granfone, 1992, Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women, Metabolism., 41, 1193, 10.1016/0026-0495(92)90008-X E.A., 1990, A low fat-diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates, J Clin. Invest., 85, 144, 10.1172/JCI114405 Hayek, 1993, J Clin. Invest., 91, 1665, 10.1172/JCI116375 Schaefer, 1983, The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females, J Clin. Endocrinol. Metab., 57, 262, 10.1210/jcem-57-2-262 Anderson, 1988, Body fat distribution, plasma lipids, and lipoproteins, Arteriosclero-sis., 8, 88, 10.1161/01.ATV.8.1.88 Lamarche, 1993, Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men, Arterioscler. Thromb., 13, 33, 10.1161/01.ATV.13.1.33 Criqui, 1980, Cigarette smoking and plasma high density lipoprotein cholesterol.The Lipid Research Clinics Program Prevalence Study, Circulation., 62 (suppl IV):, 70 Moore, 1986, Moderate alcohol consumption and coronary artery disease: a review, Medicine., 65, 242, 10.1097/00005792-198607000-00004 Suh, 1992, for the MRFIT Research Group.1992.Alcohol use and mortality from coronary heart disease: the roleof high-density lipoprotein cholesterol, Ann. Int. Med., 116, 881, 10.7326/0003-4819-116-11-881 Viilimiiki, 1986, Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake, Atherosclerosis., 59, 147, 10.1016/0021-9150(86)90043-2 Savolainen, 1990, Increased highdensity lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur, J. Clin. Invest., 20, 593 Assmann, 1991, Triglycerides and atherosclerosis. Results from the Prospective Cardiovascular Munster Study, Atheroscler. Rev., 22, 51 Seishima, 1991, Regulation of hepatic apolipoprotein synthesis in the 17 cx-ethinyl estradiol-treated rat, J. Lipid Res, 32, 941, 10.1016/S0022-2275(20)41991-1 Krauss, 1979, Effects of estrogens and progestins on high density lipoproteins, Lipids., 14, 113, 10.1007/BF02533579 Campos, 1988, Differences in low density lipoprotein subfractions and apolipoproteinsin premenopausal and postmenopausal women, J. Clin. Endocrinol. Metab., 67, 30, 10.1210/jcem-67-1-30 Wood, 1988, Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl, J. Med., 319, 1173 NIH Consensus Development Panel on triglyceride, high density lipoprotein, and coronary heart disease. 1993. Triglyceride, high density lipoprotein, and coronary heart disease. J. Am. Med. Assoc. 269: 505-510.